Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma

/PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, announced today that Dr....

Related Keywords

Portugal ,Melbourne ,Victoria ,Australia ,Zurich ,Züsz ,Switzerland ,Stockholm ,Sweden ,Swiss ,Hansa Biopharma ,Hitto Kaufmann ,Sanofi Biologics ,Prnewswire Hansa Biopharma ,Klaus Sindahl ,Stephanie Kenney ,Scripps Research Institute ,Eliza Hall Institute ,Boehringer Ingelheim ,Research Scientist ,Industrial Affairs ,Hansa Executive Committee ,Swiss Federal Institute Of Technology ,Technical University Of Braunschweig ,Global Biopharmaceutics Development ,Vp Global Corporate Affairs ,Pieris Pharmaceuticals ,Kaufmann ,Nasdaq Stockholm ,Chief Scientific Officer ,Scientific Advisory Board ,Instituto De Biologia Experimental ,Vice President ,Process Sciences ,Natural Science ,Swiss Federal Institute ,Technical University ,Scripps Research ,Hansa Biopharma Ab ,Health Care Amp Hospitals ,Biotechnology ,Medical Pharmaceuticals ,Pharmaceuticals ,Personnel Announcements ,